Delivery Order SPE2DB22D1106-SPE2DB25FEYN2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Promacta 25 mg tablets in quantities of 30 units. This contract, valued at $17,672.24, is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The ultimate completion date is set for September 30, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Promacta 25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $4,418.06 and an ultimate completion date of September 4, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order valued at $8,026.53, with performance completion scheduled for September 3, 2025. The contract involves no set-aside designation and represents a competitive award to the prime contractor. Performance will occur at AmerisourceBergen Drug Corp's corporate office location in...
- This delivery order, awarded July 30, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides $13.3K for the supply of Promacta 12.5 mg tablets (30-count units) with delivery completion required by August 20, 2025. The award utilizes firm fixed price terms under a non-competitive set-aside arrangement and is performed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's prime Indefinite...
- The Defense Logistics Agency awarded a $4,418.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Promacta 25 mg tablets (30-count units). The contract, which is a child delivery order under a larger indefinite delivery vehicle, carries an ultimate completion date of August 18, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of approximately $8,027 and is structured as a firm fixed price delivery order, with an ultimate completion date of October 20, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Promacta 25 mg tablets in quantities of 30 units, with a ceiling value of $4,418.06. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $12,029.63, with an ultimate completion date of August 20, 2025. The contract is not set-aside and represents a competitively awarded procurement. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $8,026.53 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of August 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This firm fixed price delivery order, valued at $16,053.06, represents a non-set-aside competitive award with an ultimate completion date of September 22, 2025. The pharmaceutical products will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEYN2Delivery Order
This delivery order, awarded July 18, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of Promacta 25 mg tablets in quantities of 30 units. The contract carries a ceiling value of $4,418.06 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 8, 2025. The award is unclassified as a set-aside contract, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with the place of performance also located in Conshohocken. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 7/18/25 |